Overview Twin SUBLIVAC® Grasses Clinical Efficacy Study Status: Completed Trial end date: 2007-10-01 Target enrollment: Participant gender: Summary To show that treatment with SUBLIVAC® Grasses is clinically effective by means of reduction in allergic symptoms and/or use of allergic symptomatic medication in subjects suffering from IgE mediated allergic complaints triggered by grass pollen. Phase: Phase 3 Details Lead Sponsor: HAL Allergy